Company Page

Psychedelic Medicine Association

The Psychedelic Medicine Association (PMA) is a pioneering society of physicians, therapists, and healthcare professionals dedicated to advancing education on the therapeutic uses of psychedelic medicines. Recognizing that the psychedelic revolution is here, with substances like ketamine legally used as medicine and MDMA and psilocybin on the fast track to FDA approval, PMA aims to bridge the gap between the rapid advances in psychedelic research and frontline healthcare providers. As a public benefit corporation, PMA endeavors to help physicians become comfortable discussing, recommending, and even prescribing these revolutionary treatments.

Committed to equipping medical professionals with the necessary knowledge, PMA offers various educational resources and platforms for networking and collaboration. This includes a comprehensive course designed to provide clinicians with the skills required to administer safe and effective psilocybin therapy. Through webinars, community forums, and CME/CE accredited courses, PMA ensures its members stay up-to-date with the latest industry trends and best practices.

The association has created a supportive community where members can engage in candid discussions about psychedelics, review existing research, and explore innovative ways to incorporate these treatments into their practice. Testimonials from members reflect the value they derive from the association, whether it's enriching their educational foundation, gaining insights from leaders in psychedelic research, or connecting with like-minded practitioners. With a focus on pushing the boundaries of understanding and advocating for the potential of psychedelics as medicine, the Psychedelic Medicine Association is indeed a trailblazer in this exciting field.

• Teaches: Globally
• Website: https://psychedelicmedicineassociation.org/